Why the study?
Does balloon dilatation of the aortic valve in utero improve outcomes in a fetus with critical aortic stenosis?
Does balloon dilatation of the aortic valve in utero improve outcomes in a fetus with critical aortic stenosis?
Answers are grounded in this paper and cite their sources.
In utero balloon dilatation for critical aortic stenosis did not prevent the progression of endocardial fibroelastosis or neonatal death in this case.
Fetal echocardiography has recently caused an impact on the treatment of congenital heart disease and in the field of therapeutic, cardiological intervention. The present study reports on a case of critical aortic stenosis, diagnosed in utero at 27 weeks' gestation, and in which balloon dilatation was attempted to improve the poor prognosis associated with this condition. Since the endocardium at this stage of development was apparently normal, this therapeutic intervention was attempted to avoid irreversible damage to the left ventricle. Although hydrops disappeared and the myocardium hypertrophied, endocardial fibroelastosis progressed and the neonate died within the first day of life, after surgical aortic valvotomy. More data are necessary to clarify whether endocardial fibroelastosis is really a consequence of high pressure in the left ventricle resulting from stenosis of the aortic valve or whether it is a disease, the progression of which is unavoidable once it takes hold.
No takes yet. Share an insight, caveat, or question.
Lopes et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: